Accuray Inc (ARAY) Q3 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Joseph Diaz -- Managing Partner Joshua H. Levine -- President and Chief Executive
Accuray Inc (NASDAQ: ARAY) Q3 2020 Earnings Call Transcript
Categories
Health Care
What to expect from Vertex Pharmaceuticals (VRTX) Q1 2020 earnings?
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of
Neogenomics Inc (NASDAQ: NEO) Q1 2020 Earnings Call Transcript
Neogenomics Inc (NEO) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Douglas M. VanOort -- Chairman of the Board of Directors and
Pfizer (NYSE: PFE) Q1 2020 Earnings Call Transcript
Pfizer Inc. (PFE) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman and
Merck & Co (NYSE: MRK) Q1 2020 Earnings Call Transcript
Merck & Co (MRK) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Kenneth C.
Centene Corp (NYSE: CNC) Q1 2020 Earnings Call Transcript
Centene Corp (CNC) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance & Investor Relations Michael
Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down
Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS
A visual representation of Pfizer Inc. (NYSE: PFE) Q1 2020 earnings results
Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts' forecast. Earnings, on an
Lexicon Pharmaceuticals (NASDAQ: LXRX) Q1 2020 Earnings Call Transcript
Lexicon Pharmaceuticals (LXRX) Q1 2020 earnings call dated Apr. 27, 2020 Corporate Participants: Kimberly Lee -- Head of Investor Relations and Corporate Strategy Lonnel
Delay in filing Biogen’s Alzheimer’s drug leaves analysts scratching head during conference call
Late last year, Biogen (NASDAQ: BIIB) made an announcement that left investors gung-ho. The stock soared 27% after the company optimistically said
Edwards Lifesciences Corp (NYSE: EW) Q1 2020 Earnings Call Transcript
Edwards Lifesciences Corp (EW) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations Michael A. Mussallem -- Chairman
Eli Lilly & Co (NYSE: LLY) Q1 2020 Earnings Call Transcript
Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Eli Lilly (LLY) reports Q1 2020 earnings results
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic, the company
Biogen Inc (NASDAQ: BIIB) Q1 2020 Earnings Call Transcript
Biogen Inc (BIIB) Q1 2020 earnings call dated Apr. 22, 2020 Corporate Participants: Joe Mara -- Vice President, Investor Relations Michel Vounatsos -- Chief Executive Officer
Healthcare Services Group (HCSG) Q1 2020 Earnings Call Transcript
Healthcare Services Group Inc (HCSG) Q1 2020 earnings call dated April 22, 2020 Corporate Participants: Theodore Wahl -- President & Chief Executive Officer Matthew
Quest Diagnostics Inc (NYSE: DGX) Q1 2020 Earnings Call Transcript
Quest Diagnostics Inc (DGX) Q1 2020 earnings call dated Apr. 22, 2020 Corporate Participants: Shawn Bevec -- Vice President, Investor Relations Stephen H. Rusckowski -- Chairman,
Thermo Fisher Scientific (NYSE: TMO) Q1 2020 Earnings Call Transcript
Thermo Fisher Scientific Inc (TMO) Q1 2020 earnings call dated April 22, 2020 Corporate Participants: Kenneth Apicerno -- Vice President, Investor Relations Marc N.
Infographic: Quest Diagnostics (DGX) Q1 2020 Earnings Results
Quest Diagnostics Incorporated (NYSE: DGX) reported a 40% dip in earnings for the first quarter of 2020 due to lower revenue and
Johnson & Johnson mentioned COVID 80 times during earnings call, vs. Abbott’s 16
Global pharma giants Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) announced their earnings for Q1 2020 last week. Despite
Infographic: Biogen (BIIB) Q1 2020 Earnings Results
Biogen Inc. (NASDAQ: BIIB) reported its financial results for the quarter ended March 31, 2020 today. Biogen posted a 1% decline in
Biofrontera AG (NASDAQ: BFRA) Q4 2019 Earnings Call Transcript
Biofrontera AG (BFRA) Q4 2019 earnings call dated Apr. 21, 2020 Corporate Participants: Pamela Keck -- Investor Relations Hermann Lubbert -- Chief Executive Officer Thomas Schaffer -- Chief